ESKALE study, a French real-world study describing TRD patients with Esketamine nasal spray: final analysis

ESKALE study, a French real-world study describing TRD patients with Esketamine nasal spray: final analysis

Introduction Treatment resistant depression (TRD) affects a substantial proportion of patients with depression and carries a large unmet need. Esketamine nasal spray (NS), in combination with a selective serotonin reuptake inhibitor (SSRI) or serotonin norepinephrine reuptake inhibitor (SNRI), has...

Full description

Bibliographic Details
Main Authors:	L. Samalin, L. Mekaoui, M. Rotharmel, P. de Maricourt, M.-A. Codet, E. Gaudre Wattinne
Format:	Article
Language:	English
Published:	Cambridge University Press 2023-03-01
Series:	European Psychiatry
Online Access:	https://www.cambridge.org/core/product/identifier/S0924933823002717/type/journal_article

Similar Items

ESKALE study, a French real-world study of esketamine nasal spray for patients with treatment-resistant depression
by: S. Ludovic, et al.
Published: (2022-06-01)

Esketamine in patient with treatment resistant depression: Outcome of the temporary authorization for use programme in France
by: E. Gaudre Wattinne, et al.
Published: (2021-04-01)

Pengenalan lif & eskalator /
by: Mohamed Rashid Embi 445015, et al.

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression
by: Wajs, Ewa, et al.
Published: (2020)

A Meta-Analysis of the Antidepressant Responses in Pivotal Trials on Esketamine Nasal Spray and Atypical Antipsychotics
by: Wang L, et al.
Published: (2023-12-01)

Friedrich A. Kittler: Die Eskalation der Medien
by: Till A. Heilmann, et al.
Published: (2024-02-01)

Esketamine nasal spray shows higher remission and response rates over 32 weeks of treatment compared with quetiapine extended-release in patients with treatment resistant depression: Results from ESCAPE-TRD, a randomised, phase IIIb clinical trial
by: A. Reif, et al.
Published: (2023-03-01)

Treating with esketamine nasal, will increase blood pressure?
by: V. Rosello-Molina, et al.
Published: (2021-04-01)

Management of treatment-resistant depression with esketamine nasal spray: clinical questions for daily practice in Gulf Cooperation Council countries
by: Nahida Nayaz Ahmed, et al.
Published: (2023-12-01)

Thermal Radiation Detector (TRD) Modeling
by: Mehdi Munshid Shellal
Published: (2011-01-01)

Ars Amatoria - trd prevajalski oreh?
by: Barbara Šega Čeh
Published: (2000-12-01)

Early Clinical Experiences of Esketamine Nasal Spray in the UK in Adults with Treatment-Resistant Major Depressive Disorder: Advisory Panel Recommendations
by: Young AH, et al.
Published: (2023-02-01)

Assessing the meaningful change threshold of Quality of Life in Depression Scale using data from two phase 3 studies of esketamine nasal spray
by: Heather Rozjabek, et al.
Published: (2022-07-01)

Safety of esketamine nasal spray: Analysis of post-marketing reports submitted to the FDA adverse event reporting system in the first year on the market
by: C. Gastaldon, et al.
Published: (2021-04-01)

Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant
by: Carol Jamieson, et al.
Published: (2023-05-01)

Protestzwitschern. Wie Twitter-Netzwerke zur Eskalation der G20-Proteste in Hamburg 2017 beitrugen
by: Eddie Hartmann, et al.
Published: (2020-07-01)

Treatment-Resistant Depression (TRD): Is the Opioid System Involved?
by: Shaul Schreiber, et al.
Published: (2023-07-01)

A 28-Day, Randomized, Controlled, Single-Blind, Phase 2 Study in Treatment-Resistant Major Depressive Disorder (TRD) Patients Receiving Intranasal Esketamine Comparing Addition of Almond Therapy TM with Treatment-as-Usual (TAU)
by: P. Chue, et al.
Published: (2023-03-01)

The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review
by: Ludivine Boudieu, et al.
Published: (2023-12-01)

Sheep TRD@ locus consists of a large number of TRDV elements
by: S. Ciccarese, et al.
Published: (2011-03-01)

ICEBERG study: an indirect adjusted comparison estimating the long-term benefit of esketamine nasal spray when compared with routine treatment of treatment resistant depression in general psychiatry
by: Albino J. Oliveira-Maia, et al.
Published: (2023-10-01)

Use of COMT and BDNF biomarkers to predict rTMS efficacy for TRD
by: Martha Koo, M.D., et al.
Published: (2022-09-01)

Effect of esketamine nasal drops on pain in children after tonsillectomy using low temperature plasma ablation
by: Qiu Qian, et al.
Published: (2023-07-01)

Indirect adjusted comparison of 6-month clinical outcomes between esketamine nasal spray and other real-world polypharmacy treatment strategies for treatment resistant depression: results from the ICEBERG study
by: Albino J. Oliveira-Maia, et al.
Published: (2023-10-01)

Numerical modelling of the V-J combinations of the T cell receptor TRA/TRD locus.
by: Florence Thuderoz, et al.
Published: (2010-02-01)

Guía de telemedicina para pacientes con terapias respiratorias domiciliarias (tele-TRD)
by: Salvador Díaz Lobato, et al.
Published: (2022-10-01)

A newly developed soft-type turtle releasing device (Soft-TRD) for setnet fisheries
by: Daisuke Shiode, et al.
Published: (2021-07-01)

The Genomic Organisation of the TRA/TRD Locus Validates the Peculiar Characteristics of Dromedary δ-Chain Expression
by: Serafina Massari, et al.
Published: (2021-04-01)

TRD-YOLO: A Real-Time, High-Performance Small Traffic Sign Detection Algorithm
by: Jinqi Chu, et al.
Published: (2023-04-01)

A monoclonal Trd chain supports the development of the complete set of functional γδ T cell lineages
by: Anne M. Hahn, et al.
Published: (2023-03-01)

A monoclonal Trd chain supports the development of the complete set of functional γδ T cell lineages
by: Anne M. Hahn, et al.
Published: (2023-05-01)

Research advances in the clinical application of esketamine
by: Xiao‐Xi Zhang, et al.
Published: (2022-03-01)

Nutrition + CBT + TMS: an integrative approach for depressive and anxiety symptoms for treatment-resistant depression (TRD) patients.
by: Cruz José, et al.
Published: (2023-07-01)

Growth kinetics and wear resistance of vanadium carbide on AISI D2 steel produced by TRD process
by: Lianpu Zhou, et al.
Published: (2021-01-01)

Application of Chromosome Conformation Capture Method for Detection MYC/TRD Chromosomal Translocation in Leukemia Cell Line
by: Moloud Absalan, et al.
Published: (2020-07-01)

Efficacy and Safety of Flexibly Dosed Esketamine Nasal Spray Plus a Newly Initiated Oral Antidepressant in Adult Patients with Treatment-Resistant Depression: A Randomized, Double-Blind, Multicenter, Active-Controlled Study Conducted in China and USA
by: Chen X, et al.
Published: (2023-03-01)

Nasal valve angle or nasal valve groove: Which is more suitable to describe a normal anatomic structure?
by: Baofu Yu, et al.
Published: (2023-12-01)

A comparative study of nasal final prefixes in Malay and English
by: Sharifah Raihan Syed Jaafar,
Published: (2012)

Five new Camillea (Xylariales) species described from French Guiana
by: Jacques Fournier, et al.
Published: (2023-10-01)

Assessing Nasal Epithelial Dynamics: Impact of the Natural Nasal Cycle on Intranasal Spray Deposition
by: Amr Seifelnasr, et al.
Published: (2024-01-01)